Eloquent AI | $7,400,000 | (Sep 12, 2025)
Meela Inc. | $3,500,000 | (Sep 12, 2025)
BacAlt | $2,037,362 | (Sep 12, 2025)
Kriya Therapeutics, Inc.
United States
- Morrisville, NC
- 12/09/2025
- Series D
- $320,000,000
Our mission is to revolutionize medicine, with the ultimate goal of eliminating human suffering and enabling people to live without the burden of disease. Kriya is a biopharmaceutical company developing gene therapies to address chronic diseases affecting millions of people around the world. With operations in Research Triangle Park, North Carolina, and Palo Alto, California, Kriya has raised over $900 million to advance a broad pipeline of gene therapies in ophthalmology, metabolic disease and neurology. For more information, please visit www.kriyatx.com and follow us on LinkedIn and X (Formerly Twitter).
- Industry Biotechnology Research
- Website https://kriyatherapeutics.com/
- LinkedIn https://www.linkedin.com/company/kriyatx/
Related People
Shankar Ramaswamy, M.D.Co Founder
United States -
Raleigh-Durham-Chapel Hill Area
Dr. Ramaswamy is the Co-Founder and CEO of Kriya Therapeutics, a biopharmaceutical company developing gene therapies to address diseases affecting millions of people around the world. With operations in Palo Alto, California and Research Triangle Park, North Carolina, Kriya has raised over $600 million in committed capital, which will be used to advance a broad pipeline of gene therapies for ophthalmology, neurology and metabolic disease.
Previously, Dr. Ramaswamy was part of the early foundational team at Roivant Sciences, where he was responsible for helping to identify and evaluate assets across therapeutic areas and launch its first public subsidiary company. He went on to be the Chief Business Officer of Axovant Gene Therapies.
Dr. Ramaswamy holds a medical degree from Brown University and an undergraduate degree in economics from Harvard University.
Goodpath | $18,000,000 | (Sep 12, 2025)
Quack AI | $7,000,000 | (Sep 12, 2025)
Diana Health (We're Hiring!) | $55,000,000 | (Sep 12, 2025)
OpenHealth Technologies | $3,000,000 | (Sep 12, 2025)
AegisAI Security | $13,000,000 | (Sep 12, 2025)
Clyx | $14,000,000 | (Sep 12, 2025)
TrueMeter | $4,000,000 | (Sep 11, 2025)
Noxilizer, Inc. | $30,000,000 | (Sep 11, 2025)